Sun Pharma Raises Rs 10,000 Crore in Debt to Fund Organon Acquisition
Sun Pharmaceutical Industries is raising Rs 10,000 crore through two tranches of rupee-denominated bonds to partly refinance bridge loans linked to the proposed acquisition of Organon.
The bond proceeds will partly refinance bridge loans linked to the proposed acquisition, which has an enterprise value of USD 11.75 billionSun Pharmaceutical Industries is raising Rs 10,000 crore through two tranches of rupee-denominated bonds to partly refinance bridge loans taken to fund its acqu…